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Abstract: Type 1 diabetes (T1D) is the result of the selective destruction of the pancreatic β-cells by T 
cells of the immune system. Although spleen is a secondary lymphoid organ, it is also involved in the 
T1d pathogenesis. However, the alterations in a variety of cellular processes of this disease need to be 
further understood. We aimed to analyze the benefits of resveratrol, and its complexed form on diabetic 
complications in the spleen of rats. To this end, we investigated important enzymes of phosphoryl transfer 
network, and Na+, K+-ATPase activity. Wistar rats were divided into non-diabetic groups: Control, ethanol, 
Resveratrol, Hydroxypropyl-β-cyclodextrin, Resveratrol-hydroxypropyl-β-cyclodextrin, and diabetic 
groups with the same treatments. diabetes was induced by a single dose of 60 mg/kg of streptozocin 
intraperitoneally, and treatments by intragastric gavage once daily for 60 days. Hyperglycemia reduced 
creatine kinase activity, which was reversed by the administration of resveratrol. Na+, K+-ATPase activity 
was greatly affected, but it was reversed by resveratrol and resveratrol-hydroxypropyl-β-cyclodextrin. This 
suggest an energetic imbalance in the spleen of diabetic rats, and in case this also occurs in the diabetic 
patients, it is possible that resveratrol supplementation could be beneficial to the better functioning of the 
spleen in diabetic patients. 
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INTRODUCTION
diabetes mellitus (dm) is a chronic metabolic 
disease of high complexity, being responsible 
for health problems worldwide. The dm type 
1 (dm1) is characterized by a decompensated 
energy metabolism, which causes total or partial 
autoimmune destruction of insulin-producing cells, 
resulting in high blood glucose levels (Bluestone 
et al. 2010, Nyaga et al. 2018). The spleen has a 
relevant participation in the metabolic changes of 
this disease since the splenocytes produce cytokines 
that contribute to the β-pancreatic cells destruction 
(Thorvaldson et al. 2005, García-Galicia et al. 
2014, Tong et al. 2015). It is also reported that 
splenectomy may lead to diabetes (Kabelitz et al. 
2008, ley et al. 2012).  
Streptozotocin (STZ) is usually used to 
induce type 1 diabetes in animal models (eriksson 
et al. 2000, lenzen 2008, Ghosh et al. 2018). 
‘Streptozotocin diabetes’ is caused by specific 
necrosis in the pancreatic β-cells inducing 
glucotoxicity (Wu and Yan 2015). Some natural 
antioxidants have been reported to exhibit their 
therapeutic effects in ‘streptozotocin diabetes’ 
(morishita 2004, Rugde et al. 2007, Ghosh et al. 
2018). Resveratrol is a natural phytoalexin present 
in a wide variety of plants, grapes, and red wine 
has been linked with beneficial activities towards 
health because it acts as an antioxidant, preventing 
and treating metabolic diseases such as diabetes 
(Chen et al. 2011, Chang et al. 2012). mice treated 
with resveratrol showed a significant reduction 
in the death of splenocytes. Resveratrol-induced 
autophagy of these cells, and the degradation of 
intracellular proteins and lipids provides energy 
(ATP) for the cell, preventing the activation of the 
apoptotic damage (Kim et al. 2007) and metabolic 
diseases such as dm (Gurusamy et al. 2010, lee et 
al. 2011). 
According to Baur and Sinclair (2006), 
resveratrol has a rapid metabolization due to its 
low bioavailability in the organism, being rapidly 
eliminated when administrated orally. So, an 
alternative for increasing the bioavailability is 
to complex it with cyclodextrin (Cd), which is 
capable of forming inclusion complexes with 
hydrophobic substances (Teixeira et al. 2013, 
Torres et al. 2018). Besides, the bioavailability 
may be enhanced by increasing the solubility and 
stability, and dissolution rate (Trollope et al. 2014, 
Kumar et al. 2017). 
Adenylate kinase (AK), pyruvate kinase (PK), 
and creatine kinase (CK) are the key enzymes 
participating in a network of production and cellular 
energy homeostasis (dzeja and Terzic 2003, matté 
et al. 2007, Alekseev et al. 2012). Another relevant 
enzyme for the organism is the Na+, K+-ATPase, 
responsible for generating and maintaining the 
ionic gradients through the cell membrane (Pressley 
et al. 2005, Jaitovich and Bertorello 2006). The 
nutrients and energy flow maintenance into the cell 
is essential for the homeostasis and cell work. The 
energy metabolism reduction can lead to a decrease 
in ATP synthesis. In this context, it has been shown 
that the energy metabolism deficiency may be 
implicated in the pathogenesis of several metabolic 
conditions (mattevi et al. 1996, Alves-Filho and 
Pålsson-mcdermott 2016, Xiao et al. 2018). 
One of the pathways of cellular energy 
production is the glycolytic route. PK transfers 
phosphoryl group of the phospoenolpyruvate 
(PeP) to AdP resulting pyruvate and ATP. Aizawa 
et al. (2003) demonstrated apoptotic cells in the 
splenic red pulp of the PK-deficient patient. This 
indicates that PK may be considered a key enzyme 
for the cell metabolism. CK isoforms are part of 
a buffering system of cellular energy. It occurs 
between production and consumption of ATP in 
different compartments such as mitochondria and 
cytosol, contributing to homeostasis (Wallimann 
et al. 1992, 1998, Yan 2016). Among alternative 
phosphotransfer pathways, the AK-catalysed circuit, 
in normal conditions, maintains the concentrations 
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of ATP, AdP, and AmP to equilibrium. Impaired AK 
activity leads to an alteration in cellular functions. 
In addition, AK can take over the function of other 
kinases, such as CK, in pathological conditions 
(dzeja et al. 2011, Wujak et al. 2015).
The Na+, K+-ATPase plays an important role in 
the maintenance of the Na+ across the cell membrane. 
It generates an electrochemical gradient through 
the plasmatic membrane (Erecińska and Silver 
1994, Jaitovich and Bertorello 2006) that is used 
for cellular volume regulation, osmotic balance, 
and to transport molecules (e.g. glucose) bonded 
to the co-transport of Na+ (Kaplan 2002). This 
transport is essential for cellular functioning since 
more than one-third of hydrolyzed ATP is to pump 
ions across membranes. Shi et al. (2013) suggested 
that complications of type 1 diabetes may be partly 
due to the impaired Na+, K+-ATPase activity and 
that this dysfunction may be one of the mechanisms 
of type 1 diabetes-induced complications. The 
association between resveratrol with insulin may 
be an excellent treatment for type-1 diabetes. It was 
suggested, at least in part, by anti-hyperglycemic, 
and antioxidant potential of these molecules, 
preserving regulation of Na+, K+-ATPase (Bashir 
2018). Thus, protecting the effective functioning 
of Na+, K+ -ATPase from the complications caused 
by type 1 diabetes could contribute to slow the 
progression of these injuries in this disease.
It is known that splenocytes are involved in 
the diabetes development, however, few reports 
are found about the activity of the AK, PK, CK, 
and Na+, K+-ATPase enzymes in the spleen in the 
presence and absence of resveratrol, which has 
been considered a hypoglycemic substance. The 
current study aimed to investigate the role of 
resveratrol-hydroxypropyl-β-cyclodextrin, and its 
free form on the activities of important enzymes of 




Resveratrol (C14H12O3; molecular weight = 228.25 
g/mol; purity > 98%) and 2-hydroxypropyl-β-
cyclodextrin (HPβCD) were obtained from Sigma-
Aldrich. 0.1 mM HPβCD solution in water (8 
ml) at 40 °C was prepared by vigorous stirring 
in UlTRA-TURRAX High-Speed Homogenizer 
T 25 ºC (IKA, UK) at 3,200 rpm and an equimolar 
amount of RSV (0.1 mm) was directly added to the 
suspension. The RSV was previously dissolved in 
ethanol (2 ml). After stirring for one minute, the 
suspension was filtered through 0.45 µm cellulose 
acetate membrane filter to removed undissolved 
particles. The solvent was removed by evaporation. 
The evaporation was performed using rotary 
evaporator at 40 °C for about 10 min under vacuum 
for 8 h. Since resveratrol is a photosensitive 
substance, the procedure was performed in a dark 
environment (Nishihira et al. 2017).
CHARACTeRIZATION OF THe INClUSION 
COmPleX
Fourier Transformed Infra-Red Spectroscopy 
(FT-IR) analyses were performed Perkin elmer 
(Spectrum One), R, HP and the complex spectra 
were collected using an FT-IR in a spectral region 
between 4,000 and 450 cm-1. Samples were mixed 
in a pestle with potassium bromide (KBr) (1:100) 
and pressed in a hydraulic press (10 tons for 2 
min) to small tablet and were placed in the infrared 
beam. Nuclear magnetic resonance (NmR) spectra 
were performed in BRUKeR dPX-400 (Bruker, 
Germany). Fifteen grams of samples were dissolved 
in dmSO-d6 using tetramethylsilane (TmS) as 
internal reference standard.  The characterization 
was carried out in the laboratório de Química of 
the Universidade Federal de Santa maria (UFSm).
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ANImAl mOdel
Seventy male Wistar rats from the Central Animal 
House of UFSm were submitted to a period of 15 
days for adaptation. The animals with 60 days old 
and weighing an average and standard deviation of 
216 ± 28 g were used in this experiment. The rats 
were kept in cages, four animals each, housed at a 
constant temperature and controlled humidity (23 ± 
1 ºC and 70%, respectively) on a light/ dark cycle 
of 12 h. They had free access to commercial ration 
and water. All animal procedures were approved 
by the Animal ethics Committee from Franciscan 
University (protocol under number: 14/2012). 
eXPeRImeNTAl INdUCTION OF dIABeTeS
Hyperglycemia was provoked by a single 
intraperitoneal injection of 60 mg streptozotocin 
(STZ)/kg body mass of rat, dissolved in 0.1 m 
sodium citrate buffer (pH 4.5), after fasting period 
of 12 h. The animals to normoglycemic group 
received an equivalent volume of sodium citrate 
buffer. STZ-treated rats received 5% glucose 
solution instead of water for 24 h after diabetes 
induction to avoid death due to hypoglycemic 
shock (Avila-Acevedo et al. 2012). Blood samples 
were taken from the tail vein five days after STZ or 
vehicle administration to measure glucose levels. 
Glycemia was determined by using a commercial 
glucometer (Accu-Chek Performa, Roche®, USA). 
Animals with fasting glycemia higher than 200 mg/
dl (Barbalho et al. 2011) were used for the diabetic 
group (Fig. 1). 
TReATmeNT WITH ReSVeRATROl
After measuring glycemia, seventy rats were 
primarily divided into two groups (normal and 
hyperglycemic). The normoglycemic rats were 
divided into five groups, with seven animals 
each: Control (C); ethanol (e); Resveratrol (R); 
Resveratrol-hydroxypropyl-β-cyclodextrin (RHP) 
and Hydroxypropyl-β-cyclodextrin (HP). The 
hyperglycemic rats were divided into five groups, 
with seven animals each: diabetic Control (dC); 
diabetic ethanol (de); diabetic Resveratrol 
(DR); Diabetic Resveratrol-hydroxypropyl-β-
cyclodextrin (dRHP) and diabetic Hydroxypropyl-
β-cyclodextrin (DHP). Still on the fifth day was 
initiated the sixty-day chronic treatment with 1 daily 
administration, by intragastric gavage of water to 
the controls C and d (Figure 1). Resveratrol was 
dissolved in ethanol at 15% of aquose solution. A 
solution of 1 mg R/kg body mass was administered 
to R and dR groups and 15% ethanol solution 
to e and de groups. 1 mg of R in the complex/
kg body mass to RHP and dRHP groups and the 
equivalent concentration of HP to the one found in 
the complex to HP and dHP groups. RSV dosage 
choice of 1 mg/kg was based on previous studies, 
which authors observed hypoglycemic effect even 
in low dose (Chang et al. 2011, 2012).
TISSUe PRePARATION 
The rats were killed by decapitation without 
anesthesia, and the spleen was rapidly dissected, 
weighted and kept chilled until homogenization, 
which was performed using a ground glass type 
Potter-elvejhem homogenizer (1:10 w/v) in 
buffer (pH 7.4) containing 0.32 M sucrose, 1 mM 
eGTA, 10 mm Tris-HCl. The homogenized was 
centrifuged at 800 × g for 10 min at 4 °C, and part 
of the supernatant was aliquotted to determine the 
AK and CK total activity. The other part of the 
supernatant was centrifuged at 10,000 × g for 15 
min at 4 °C, and the supernatant was separated 
to determine the PK activity. Another spleen 
fraction was homogenized in buffer medium, pH 
7.5 and centrifuged at 800 x g for 10 min at 4 °C. 
The supernatant was used for the determination 
of the Na+, K+-ATPase enzymatic activity. The 
supernatants were stored for no more than 1 week 
at -80 °C when the assay was not carried out 
immediately.
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AdeNYlATe KINASe ACTIVITY 
AK activity was measured with an assay containing 
hexokinase (HK) and glucose 6-phosphate 
dehydrogenase (G6Pd), according to dzeja et al. 
(1999). The reaction mixture contained 20 mm 
glucose, 100 mm KCl, 20 mm HePeS, 1 mm 
edTA, 4 mm mgCl2, 2 mm NAdP
+, 4.5 U/ml 
of HK, 2 U/mL of G6PD, and 1 µg of protein 
homogenate. The reaction was initiated by adding 
2 mm AdP. The reduction of NAdP+ was followed 
at 340 nm for 3 min in a spectrophotometer. AdP, 
NAdP+, G6Pd, and HK were dissolved in water. 
Reagents concentration and assay time (3 min) 
were chosen to assure the linearity of the reaction. 
The results were expressed in nanomol of ATP 
formed per min per mg of protein.    
PYRUVATe KINASe ACTIVITY 
PK activity was assayed according to Feksa et al. 
(2003). The assay consisted of 0.1 m Tris/HCl 
buff er, pH 7.5, 0.16 mM NADH, 10 mM MgCl2, 75 
mm KCl, 5.0 mm AdP, 0.1% (v/v) Triton X-100, 
7 U of L-lactate dehydrogenase, and 10 µL of the 
mitochondria-free supernatant in a final volume of 
0.5 ml. After 10 min of pre-incubation at 37 ºC, 
the reaction was started by the addition of 1 mm 
phosphoenol pyruvate. Results were expressed as 
µmol of pyruvate per min per mg of protein.
CReATINe KINASe ACTIVITY
CK activity was assayed in the mixture containing 
the following final concentrations: 65 mM 
Tris–HCl buffer, pH 7.5, 9 mm  mgSO4,7 
mM phosphocreatine, and 1 µg of protein in a 
final volume of 0.1 mL. After 10 min of pre-
incubation at 37 ºC, the reaction was started by 
the addition of 0.3 µmol of ADP. The reaction 
was stopped after 10 min by the addition of 1 
µmol of ρ-hydroxymercuribenzoic acid. The 
incubation time and the reagent concentrations 
were chosen to assure linearity of the enzymatic 
reaction. Appropriate controls were carried out to 
measure chemical hydrolysis of phosphocreatine. 
The creatine formed was measured according 
to the method of Hughes (1962). The color was 
formed by the addition of 0.1 mL 2% α-naphthol 
and 0.1 mL 0.05% diacetyl in a final volume of 1 
ml and read after 20 min at 540 nm. Results were 
expressed as nanomol of creatine formed per min 
per mg of protein.
NA+, K+-ATPase ACTIVITY 
The reaction mixture for Na+, K+-ATPase activity 
assay contained 5.0 mm mgCl2, 80.0 mm NaCl, 
20.0 mm KCl, and 40.0 mm Tris–HCl, pH 7.4, 
in a final volume of 200 mL. After 10 min of pre-
incubation at 37 ºC, the reaction was started by the 
addition of ATP to a final concentration of 3.0 mM 
and was incubated for 20 min. Controls were carried 
Figure 1 - Schematic view of the experimental protocol. experimental induction of diabetics was provoked by a single intraperitoneal 
injection of 60 mg streptozotocin (STZ)/kg body mass of rat. Treatment refers to the C (Control), e (ethanol), R (Resveratrol), RHP 
(Resveratrol-hydroxypropyl-β-cyclodextrin), HP (Hydroxypropyl-β-cyclodextrin), DC (Diabetic control), DE (Diabetic ethanol), 
DR (Diabetic resveratrol), DRHP (Diabetic resveratrol-hydroxypropyl-β-cyclodextrin) and DHP (Diabetic Hydroxypropyl-β-
cyclodextrin).
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out under the same conditions with the addition 
of 1.0 mm ouabain. Na+, K+-ATPase activity was 
calculated by the diff erence between the two assays 
(Wyse et al. 1999). Released inorganic phosphate 
(Pi) was determined by the method of Chan et al. 
(1986), and enzyme specific activity was expressed 
as nmol of Pi released per min per mg of protein.
PROTeIN CONTeNT
Protein content of spleen homogenates was 
determined by the methods of lowry et al. (1951) 
to AK, PK and CK and Bradford (1976) to Na+, K+-
ATPase, using serum bovine albumin as the standard.
BlOOd GlUCOSe leVelS
Before the experiment, there were no signifi cant 
diff erences between blood glucose of groups. Sixty 
days after to start the treatments, all rats were 
weighed, killed, and the blood was collected for 
serum levels glucose analysis. This was determined 
in an automated analyzer Vitros 250 (Ortho-Clinical 
diagnostics), using kits Johnson & Johnson® by the 
method chemical dried.
STATISTICAl ANAlYSIS
Results were presented as the mean ± standard 
deviation (Sd). Assays were performed in duplicate 
or triplicate, and the mean or median was used for 
statistical analysis. data were analyzed using one-
way analysis of variance (ANOVA) followed by the 
post-hoc Tukey’s multiple comparison tests when F 
values were signifi cant. Diff erences between groups 
were rated signifi cantly at p < 0.05. All analyses 
were carried out using the GraphPad software.
RESULTS
eFFeCTS OF TReATmeNTS ON BlOOd GlUCOSe 
leVelS 
Streptozotocin diabetes showed a significant 
increase in the blood glucose compared to normal 
levels [F9,43 = 288.4], (p = 0.000). In relation 
to treatments, neither resveratrol free form, nor 
resveratrol-hydroxypropyl-β-cyclodextrin was able 
to revert hyperglycemia (Figure 2). 
eFFeCTS OF TReATmeNTS ON eNZYme 
ACTIVITIeS
The AK activity was neither changed by 
streptozotocin diabetes, nor treatments in the 
spleen when compared to controls [F9,60 = 1.5], (p
= 0.153) (Figure 3a). In the PK activity, ANOVA 
shows that there was no signifi cant diff erence (p
> 0.05) between the non-diabetic and the diabetic 
control. All treatments reduced PK activity, when 
compared to control (Figure 3b). The CK activity 
was reduced by hyperglycemia when compared to 
the control group (p < 0.05). The administration of 
the ethanol, and resveratrol prevented it. Already, 
the administration of resveratrol-hydroxypropyl-
β-cyclodextrin (RHP), as free cyclodextrin (HP) 
Figure 2 - Eff ects of free and resveratrol-hydroxypropyl-β-
cyclodextrin administration on plasma glucose concentration 
of non-diabetic and diabetic rats. data are mean ± standard 
deviation (Sd) for 5-7 animals in each group. data from 
blood glucose are expressed as mg/dl. C (Control), e 
(ethanol), R (Resveratrol), RHP (Resveratrol-hydroxypropyl-
β-cyclodextrin), HP (Hydroxypropyl-β-cyclodextrin), DC 
(diabetic control), de (diabetic ethanol), dR (diabetic 
resveratrol), dRHP (diabetic resveratrol-hydroxypropyl-
β-cyclodextrin) and DHP (Diabetic Hydroxypropyl-β-
cyclodextrin). Groups with diff erent letters have signifi cant 
diff erences (p < 0.05) (one-way ANOVA followed by Tukey 
test).
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reduced enzyme activity in normoglycemic 
rats (p < 0.001) (Figure 3c). Na+, K+-ATPase 
activity increased with administration of free 
resveratrol in normoglycemic animals (p < 0.001). 
Hyperglycemia caused an expressive reduction of 
the activity of the Na+, K+-ATPase activity (p < 
0.001), which was prevented by free and resveratrol-
hydroxypropyl-β-cyclodextrin (DR and DRHP 
groups) administration. Ethanol, and HPβCD failed 
to prevent it, indicating that only treatments with 
the presence of resveratrol prevented this change 
(Figure 3d).
BOdY ANd SPleeN WeIGHT
All diabetic groups reduced body weight when 
compared to non-diabetic groups (p < 0.001). 
There was no difference between treatments 
(Figure 4a). ethanol, resveratrol-hydroxypropyl-
β-cyclodextrin, and HPβCD treatment reduced the 
weight of diabetic spleen (Figure 4b).
DISCUSSION
The present study shows a reduction in the activity 
of some important spleen enzymes caused by 
Figure 3 - Eff ects of free and resveratrol-hydroxypropyl-β-cyclodextrin administration on enzyme activities in spleen of 
non-diabetic and diabetic rats. (a) AK activity (b) PK activity (c) CK activity (d) Na+, K+-ATPase activity. data are mean 
± standard deviation (Sd) for 5-7 animals in each group. C (Control), e (ethanol), R (Resveratrol), RHP (Resveratrol- 
hydroxypropyl-β-cyclodextrin), HP (Hydroxypropyl-β-cyclodextrin), DC (Diabetic control), DE (Diabetic ethanol), DR 
(Diabetic resveratrol), DRHP (Diabetic resveratrol-hydroxypropyl-β-cyclodextrin) and DHP (Diabetic Hydroxypropyl-
β-cyclodextrin). *p < 0.05; **p < 0.01; ***p < 0.001 compared to non-diabetic control and ###p < 0.001 when compared 
to diabetic control (one-way ANOVA followed by Tukey test).
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hyperglycemia, which may alter the energetic 
homeostasis of this tissue in type 1 diabetes. CK, 
and Na+, K+-ATPase activities were recovered 
by resveratrol, and resveratrol-hydroxypropyl-β-
cyclodextrin, and its free form, respectively.
The spleen is a secondary lymphoid organ 
involved in the type 1 diabetes pathogenesis 
(Ghosh et al. 2018). This disease is marked by 
alterations in a variety of cellular processes that 
need to be further understood (Badr et al. 2015). 
For the fi rst time, we measured activities of the 
phosphotransfer network, and Na+, K+-ATPase in 
the spleen of hyperglycemic rats, in the presence of 
the resveratrol complexed with HPβCD, or its free 
form. Here, streptozotocin increased blood glucose, 
and reduced body and spleen weight, as expected. 
Unfortunately, resveratrol treatment (complexed 
or not) not reverted hyperglycemia. Curiously, 
hyperglycemia was more severe with ethanol and 
HPβCD treatment. Persistent hyperglycemia can 
lead to ketoacidosis, a serious condition associated 
with very high blood glucose levels in type 1 
diabetes. Besides, it can happen associated with 
alcohol abuse in diabetics (Bradford et al. 2017, 
Umpierrez and Freire 2002), suggesting that ethanol 
treatment could have developed this condition in 
our diabetic animals. 
moreover, a positive effect of resveratrol, 
against possible death of splenocytes, was 
observed. even though the treatments did not 
aff ect the weight of spleens in the normoglycemic 
rats, hyperglycemic spleen had a reduction in the 
weight with all treatments, except resveratrol. 
Similar protection was shown by Szkudelski and 
Szkudelska (2011), which reported a signifi cant 
reduction in the death of splenocytes from mice 
treated with resveratrol. Besides, weight loss of the 
spleen may be related to body weight reduced of 
the diabetic animals, once ‘streptozotocin diabetes’ 
significantly decreases body weight of the rats 
(Zafar and Naeem-ul-Hassan Naqvi 2010). 
Intracellular processes regulate the mechanisms 
involved in energy homeostasis. For a correct 
functioning of the cell energy system is necessary that 
energy compounds, such as ATP, are synthesized and 
delivered to the consumption spots in an appropriate 
speed for its use rate (dzeja et al. 2002).  Coupling 
of spatially separated intracellular ATP producing, 
Figure 4 - Weight of non-diabetic and diabetic rats treated with free and resveratrol-hydroxypropyl-β-cyclodextrin administration. 
(a) Body weight (b) Weight of Spleen. data are mean ± standard deviation (Sd) for 5-7 animals in each group. data from body 
weight are expressed as g. C (Control), E (Ethanol), R (Resveratrol), RHP (Resveratrol- hydroxypropyl-β-cyclodextrin), HP 
(Hydroxypropyl-β-cyclodextrin), DC (Diabetic control), DE (Diabetic ethanol), DR (Diabetic resveratrol), DRHP (Diabetic 
Resveratrol- hydroxypropyl-β-cyclodextrin) and DHP (Diabetic Hydroxypropyl-β-cyclodextrin). *p < 0.5; **p < 0.01; *** p < 
0.001 compared to non-diabetic control (one-way ANOVA followed by Tukey test).
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and ATP consuming processes is fundamental to 
maintenance of cellular activities. AK, CK, and 
PK are key enzymes arranged to maintain energy 
homeostasis. In particular, PK support high energy 
phosphoryl transfer and signal communication 
between ATP generating, and ATP consuming/ATP 
sensing processes (Franceschi et al. 2013). As these 
systems operate together, a reduced enzymatic activity 
may be compensated by increased activity of the others 
enzymes. However, a change in the activity of two or 
more enzymes can lead to a cumulative impairment 
in communication between sites of production and 
consumption of ATP (dzeja and Terzic 2003). In this 
study, neither hyperglycemia, nor treatments were 
able to alter AK and PK activities. It is crucial in 
homeostasis of the adenine nucleotides metabolism, 
as well in regulating intracellular ATP, and to produce 
processes through complex phosphoryl transfer 
networks (dzeja and Terzic 2003).
PK is a critical enzyme to energy metabolism in 
the mammalian tissues. It is a crucial enzyme of the 
glucose metabolism, the main pathway that provides 
energy for cell function (Hall and Cottam 1978). 
In this study, all treatments reduced PK activity in 
all groups. We observed that RHP did not show 
the expected effects, once the administration of this 
complex decrease, even more, the enzyme activity, 
when compared to resveratrol and HP separately. 
Deficiency of this enzyme causes a decline in ATP 
production, leading to the destruction of red blood 
cells present in the spleen (Rüfer and Wuillemin 
2013). 
We also tested the effects of hyperglycemia and 
treatments on the total CK activity in the spleen. We 
found that RHP, and HP administration decreased 
the CK activity, independent of the hyperglycemia. 
However, resveratrol, and ethanol reverted this 
effect in hyperglycemic animals. The reduction of 
CK activity by hyperglycemia was not compensated 
by other enzymes evaluated in this work, such as 
PK, AK and Na+, K+-ATPase, which leads us to 
believe that there is an injury to the spleen tissue. 
Na+, K+-ATPase activity was significantly inhibited 
by hyperglycemia. Resveratrol complexed or not, 
reversed it, indicating that resveratrol can recover 
the changes of CK, and Na+, K+-ATPase activities 
in the spleen provoked by diabetes. Resveratrol 
is suggested as a preventive agent for cerebral 
ischemia. The administration of resveratrol before 
cerebral ischemia, brought Na+, K+-ATPase activity 
in the cortex, and hippocampus back to normal levels 
(Simão et al. 2011). Furthermore, it is suggested 
that the elimination of ROS contributes, in part, to 
the resveratrol-induced neuroprotection. However, 
more tests are necessary to elucidate the activity of 
Na+, K+-ATPase in the spleen, once these enzymatic 
dosages performed could have been distorted by 
interferents, like another cell line (erythrocytes), due 
to its function of the blood filtering. 
Although the formulations were tested in a 
particular organ in this work, the measurements 
of enzymatic activities evaluated in this study are 
unique in the literature. The presence of PK, AK, 
and CK already been confirmed in different animal 
species including human (Böckelmann and Ritter 
1968, Brock 1970, Fauquier et al. 2008), however, 
more studies are required for a better understanding 
about splenic bioenergetics. Furthermore, 
additional data are necessary to reinforce the 
efficacy of the performed analysis and to certify 
that the data obtained truly belongs to the spleen 
enzymes, once it is a path organ for other cells that 
could influence the results.
CONCLUSION
Based on this study, we concluded that resveratrol, 
and resveratrol-hydroxypropyl-β-cyclodextrin 
can recover the enzymatic changes in the spleen 
provoked by hyperglycemia in rats. Therefore, 
resveratrol, as a potential therapeutic agent, may 
hold promise auxiliary supplementation to the 
better functioning of the spleen in diabetic patients.
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